Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline For Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Kahn Swick & Foti, LLC (KSF) has notified investors of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) about a class action securities lawsuit. The lawsuit seeks to recover losses for investors who allegedly suffered damages due to securities fraud between August 3, 2023, and December 26, 2025. The deadline for investors to apply to be lead plaintiff in the lawsuit is April 6, 2026, following a significant drop in Ultragenyx’s stock price after the announcement of failed Phase 3 clinical trials for its drug setrusumab.